Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics Market Cap

Sarepta Therapeutics has a market cap or net worth of $1.9 billion as of June 30, 2026. Its market cap has decreased by -46.64% in one year.

• Market Cap: 1.90B
• Enterprise Value: 2.29B
• 1-Year Change: -46.64%
• Ranking: #2162
• Category: Small-Cap
• Stock Price: $17.97

Market Cap Chart

Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $1.90B, an increase of 3,148.64%. That is a compound annual growth rate of 13.44%.

Market Cap History

Date	Market Cap	% Change
Jun 30, 2026	1.90B	-15.87%
Dec 31, 2025	2.26B	-80.58%
Dec 31, 2024	11.61B	28.75%
Dec 29, 2023	9.02B	-20.70%
Dec 30, 2022	11.37B	45.06%
Dec 31, 2021	7.84B	-41.72%
Dec 31, 2020	13.45B	39.87%
Dec 31, 2019	9.62B	31.90%
Dec 31, 2018	7.29B	102.79%
Dec 29, 2017	3.60B	140.16%
Dec 30, 2016	1.50B	-14.27%
Dec 31, 2015	1.75B	192.17%
Dec 31, 2014	597.80M	-21.92%
Dec 31, 2013	765.60M	16.58%
Dec 31, 2012	656.70M	549.55%
Dec 30, 2011	101.10M	-57.54%
Dec 31, 2010	238.10M	47.70%
Dec 31, 2009	161.20M	244.44%
Dec 31, 2008	46.80M	-38.26%
Dec 31, 2007	75.80M	-54.99%
Dec 29, 2006	168.40M	10.50%
Dec 30, 2005	152.40M	79.51%
Dec 31, 2004	84.90M	-33.15%
Dec 31, 2003	127.00M	-3.93%
Dec 31, 2002	132.20M	-47.73%

View and export this data all the way back to 1998. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jun 30, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jul 1, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Absci	1.92B
AnaptysBio	1.92B
Tyra Biosciences	1.91B
Iovance Biotherapeutics	1.88B
Nanobiotix	1.80B
Zymeworks	1.76B
UroGen Pharma	1.76B
Vir Biotechnology	1.75B